{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:40:09Z","timestamp":1789123209292,"version":"build-2803163510"},"reference-count":181,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>ER+ (estrogen receptor positive) breast cancer is the most common subtype of breast cancer, for which endocrine therapy is the primary treatment. However, the development of drug resistance severely limits the clinical efficacy. In recent years, lipid metabolism reprogramming, as a key metabolic feature of tumor cells adapting to microenvironmental stress and driving progression and metastasis, has gained increasing attention due to its role in promoting endocrine therapy resistance. This review focuses on the lipid metabolism reprogramming that occurs in ER+ breast cancer cells in response to endocrine therapy, systematically elaborating on the key molecular mechanism changes in fatty acid synthesis, cholesterol metabolism, lipid droplet homeostasis, and mitochondrial fatty acid \u03b2-oxidation. These metabolic remodeling processes not only provide survival advantages and energy to drug-resistant cells but also directly promote the formation and development of drug-resistant phenotypes by affecting signal transduction and epigenetic regulation pathways. By integrating the latest research progress in this field, this article aims to deeply reveal the intrinsic connection between lipid metabolism reprogramming and endocrine resistance, providing important theoretical basis and direction for overcoming the bottleneck of drug resistance and developing new combination therapy strategies targeting lipid metabolism.<\/jats:p>","DOI":"10.3389\/fonc.2026.1848165","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:54:21Z","timestamp":1789120461000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid metabolism reprogramming: key mechanism of breast cancer endocrine therapy resistance"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhiqi","family":"Sui","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaochun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin Medical University","place":["Harbin, Heilongjiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00913","article-title":"Selective estrogen receptor degraders (SERDs): a promising strategy for estrogen receptor positive endocrine-resistant breast cancer","volume":"63","author":"Lu","year":"2020","journal-title":"J Med Chem"},{"key":"B2","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1016\/j.canlet.2021.05.030","article-title":"A basic review on estrogen receptor signaling pathways in breast cancer","volume":"24","author":"Clusan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1448687","article-title":"Mechanisms of endocrine resistance in hormone receptor-positive breast cancer","volume":"14","author":"Gao","year":"2024","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12122700","article-title":"Current therapeutic opportunities for estrogen receptor mutant breast cancer","volume":"12","author":"Palaniappan","year":"2024","journal-title":"Biomedicines"},{"key":"B5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13058-021-01462-3","article-title":"ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer","volume":"23","author":"Brett","year":"2021","journal-title":"Breast Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01394-w","article-title":"Targeting the PI3K\/AKT\/mTOR pathway in hormone-positive breast cancer","volume":"80","author":"Nunnery","year":"2020","journal-title":"Drugs"},{"key":"B7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.37349\/etat.2022.00078","article-title":"Role of PI3K\/Akt\/mTOR pathway in mediating endocrine resistance: concept to clinic","volume":"3","author":"Skolariki","year":"2022","journal-title":"Explor Targeted Anti-Tumor Ther"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.1038\/s41467-022-32828-6","article-title":"High p16 expression and heterozygous RB1 loss are biomarkers for CDK4\/6 inhibitor resistance in ER+ breast cancer","volume":"13","author":"Palafox","year":"2022","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1101\/2024.12.28.630631","article-title":"Metabolic switch in endocrine resistant estrogen receptor positive breast cancer","author":"Brechbuhl","year":"2024","journal-title":"bioRxiv"},{"key":"B10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13058-025-01991-1","article-title":"Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells","volume":"27","author":"Ward","year":"2025","journal-title":"Breast Cancer Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1158\/0008-5472.CAN-23-0184","article-title":"Metabolomic rewiring promotes endocrine therapy resistance in breast cancer","volume":"84","author":"Ahn","year":"2024","journal-title":"Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/or.2025.1564642","article-title":"Treating ER-positive breast cancer: a review of the current FDA-approved SERMs and SERDs and their mechanisms of action","volume":"19","author":"Kim","year":"2025","journal-title":"Oncol Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153898","article-title":"FE65 defines the efficacy of tamoxifen treatment via osteopontin expression in estrogen receptor-positive breast cancer","volume":"234","author":"Xu","year":"2022","journal-title":"Pathol Res Pract"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S380925","article-title":"Oral selective estrogen receptor degraders (SERDs) in breast cancer: advances, challenges, and current status","author":"Downton","year":"2022","journal-title":"Drug Des Dev Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2025.105913","article-title":"Integrative analysis of RNA expression signatures and recurrent genomic alterations before treatment: link to menopausal status, short-term endocrine therapy response and disease-free survival in luminal breast cancer","volume":"10","author":"Zhang","year":"2025","journal-title":"ESMO Open"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4414887\/v1","article-title":"Predictors of endocrine resistance in a cohort of Mexican breast cancer patients","author":"Gonz\u00e1lez-Ru\u00edz","year":"2024","journal-title":"Res Square"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1159\/000508675","article-title":"Endocrine-resistant breast cancer: mechanisms and treatment","volume":"15","author":"Hartkopf","year":"2020","journal-title":"Breast Care"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18020242","article-title":"Real-world clinical experience of first-line ribociclib combined with an aromatase inhibitor in metastatic breast cancer","volume":"18","author":"Cvetanovi\u0107","year":"2026","journal-title":"Cancers"},{"key":"B19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10549-019-05517-0","article-title":"Histone methyltransferases regulate the transcriptional expression of ER\u03b1 and the proliferation of tamoxifen-resistant breast cancer cells","volume":"180","author":"Kim","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16030678","article-title":"Macrophages promote subtype conversion and endocrine resistance in breast cancer","volume":"16","author":"Zhang","year":"2024","journal-title":"Cancers"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1214648","article-title":"Research progress of exosomes in drug resistance of breast cancer","volume":"11","author":"Liu","year":"2024","journal-title":"Front Bioeng Biotechnol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16196","article-title":"Eribulin treatment promotes re-expression of estrogen receptor in endocrine therapy-resistant hormone receptor-positive breast cancer cells","volume":"43","author":"Goto","year":"2023","journal-title":"Anticancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-01959-1","article-title":"Annotation-free deep learning algorithm trained on hematoxylin & eosin images predicts epithelial-to-mesenchymal transition phenotype and endocrine response in estrogen receptor-positive breast cancer","volume":"27","author":"Hu","year":"2025","journal-title":"Breast Cancer Res"},{"key":"B24","first-page":"152392","article-title":"Metabolic reprogramming: The driving force behind cancer drug resistance","author":"El-Sehrawy","year":"2025"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071715","article-title":"Hypoxia, metabolic reprogramming, and drug resistance in liver cancer","volume":"10","author":"Bao","year":"2021","journal-title":"Cells"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.942064","article-title":"Relationship between metabolic reprogramming and drug resistance in breast cancer","volume":"12","author":"Lv","year":"2022","journal-title":"Front Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2023.05.001","article-title":"The role of extracellular vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: consequences for drug resistance","volume":"73","author":"Pol\u00f3nia","year":"2023","journal-title":"Cytokine Growth Factor Rev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.875318","article-title":"Novel insights on lipid metabolism alterations in drug resistance in cancer","volume":"10","author":"Yang","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101376","article-title":"Lipid metabolism involved in progression and drug resistance of breast cancer","volume":"12","author":"Fu","year":"2025","journal-title":"Genes Dis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2025.106816","article-title":"Research progress of lipid metabolism reprogramming and related drug therapy in ovarian cancer","volume":"253","author":"Li","year":"2025","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3724\/abbs.2023068","article-title":"Ginsenoside Rh3 induces pyroptosis and ferroptosis through the Stat3\/p53\/NRF2 axis in colorectal cancer cells: ginsenoside Rh3 has anti-colorectal cancer properties","volume":"55","author":"Wu","year":"2023","journal-title":"Acta Biochim Biophys Sin"},{"key":"B32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3892\/ijo.2025.5796","article-title":"Role of metabolic reprogramming of CAFs in tumor development and progression","volume":"67","author":"Li","year":"2025","journal-title":"Int J Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1573686","article-title":"Organoid models of ovarian cancer: resolving immune mechanisms of metabolic reprogramming and drug resistance","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.20517\/cdr.2024.81","article-title":"Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers","volume":"7","author":"Shi","year":"2024","journal-title":"Cancer Drug Resistance"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70358","article-title":"Metabolic reprogramming: a crucial contributor to anticancer drug resistance","volume":"6","author":"Zhu","year":"2025","journal-title":"MedComm"},{"key":"B36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevOncog.2024056468","article-title":"Understanding the role of the microbiome in breast cancer progression","volume":"30","author":"Kumari","year":"2025","journal-title":"Crit Rev Oncog"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101521","article-title":"Landscape of metabolic alterations and treatment strategies in breast cancer","volume":"12","author":"Wu","year":"2025","journal-title":"Genes Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2025.2786","article-title":"SGLT2 inhibitors as systemic metabolic modulators: linking glucose excretion to liver function restoration","volume":"40","author":"Noh","year":"2025","journal-title":"Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","first-page":"127672","DOI":"10.1016\/j.envpol.2026.127672","article-title":"Developmental and metabolic toxicity of diphenyl phosphate: insights from an integrative mechanistic framework in zebrafish embryos","author":"Li","year":"2026","journal-title":"Environ pollut"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/biology9010016","article-title":"Glucose favors lipid anabolic metabolism in the invasive breast cancer cell line MDA-MB-231","volume":"9","author":"Oca\u00f1a","year":"2020","journal-title":"Biology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s40001-025-02659-4","article-title":"The correlation between obesity and the occurrence and development of breast cancer","volume":"30","author":"Hu","year":"2025","journal-title":"Eur J Med Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207661","article-title":"Fatty acid synthase is a key enabler for endocrine resistance in heregulin-overexpressing luminal b-like breast cancer","volume":"21","author":"Menendez","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-021-0830-0","article-title":"Research progress on FASN and MGLL in the regulation of abnormal lipid metabolism and the relationship between tumor invasion and metastasis","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2024.159592","article-title":"The interplay of transcriptional regulator SREBP1 with AMPK promotes lipid biosynthesis in Mucor circinelloides WJ11","volume":"1870","author":"Naz","year":"2025","journal-title":"Biochim Biophys Acta (BBA)-Molecular Cell Biol Lipids"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2174\/0113894501387287250611095023","article-title":"Lipidomics in breast cancer: decoding metabolic reprogramming and unlocking therapeutic opportunities","volume":"26","author":"Singhai","year":"2025","journal-title":"Curr Drug Targets"},{"key":"B47","doi-asserted-by":"publisher","first-page":"18549","DOI":"10.1038\/s41598-023-45764-2","article-title":"Lipidome and metabolome analyses reveal metabolic alterations associated with MCF-7 apoptosis upon 4-hydroxytamoxifen treatment","volume":"13","author":"Nishimoto","year":"2023","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mco2.27","article-title":"Lipid metabolism in cancer progression and therapeutic strategies","volume":"2","author":"Fu","year":"2021","journal-title":"MedComm"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/metabo10070289","article-title":"Metabolic reprogramming of chemoresistant cancer cells and the potential significance of metabolic regulation in the reversal of cancer chemoresistance","volume":"10","author":"Chen","year":"2020","journal-title":"Metabolites"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-023-02902-4","article-title":"RBM45 reprograms lipid metabolism promoting hepatocellular carcinoma via Rictor and ACSL1\/ACSL4","volume":"43","author":"Wang","year":"2024","journal-title":"Oncogene"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18073575","article-title":"Expanding roles of de novo lipogenesis in breast cancer","volume":"18","author":"Simeone","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00183-y","article-title":"Fatty acid synthesis is required for breast cancer brain metastasis","volume":"2","author":"Ferraro","year":"2021","journal-title":"Nat Cancer"},{"key":"B53","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s11033-025-10775-x","article-title":"SREBP-1 in obesity-induced breast cancer: mechanisms and therapeutic perspectives","volume":"52","author":"Tiwari","year":"2025","journal-title":"Mol Biol Rep"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189335","article-title":"Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects","volume":"1880","author":"Hou","year":"2025","journal-title":"Biochim Biophys Acta (BBA)-Reviews Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1101\/2025.05.15.653365","article-title":"PML1-mediated feedforward loop through PI3K and MAPK axes drives endocrine resistance","author":"Wang","year":"2025","journal-title":"bioRxiv"},{"key":"B56","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41417-023-00683-2","article-title":"Tafazzin mediates tamoxifen resistance by regulating cellular phospholipid composition in ER-positive breast cancer","volume":"31","author":"Li","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"B57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3724\/zdxbyxb-2021-0054","article-title":"Interaction between RAS gene and lipid metabolism in cancer","volume":"50","author":"Zhang","year":"2021","journal-title":"J Zhejiang Univ (Medical Sciences)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13058-020-01312-8","article-title":"Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression","volume":"22","author":"Asperger","year":"2020","journal-title":"Breast Cancer Res"},{"key":"B59","doi-asserted-by":"publisher","first-page":"189509","DOI":"10.1016\/j.bbcan.2025.189509","article-title":"Targeting palmitoylation: A novel frontier in cancer biology and immunotherapy","author":"Yang","year":"2025","journal-title":"Biochim Biophys Acta (BBA)-Reviews Cancer"},{"key":"B60","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41419-026-08460-3","article-title":"CD36 enhances sensitivity of triple negative breast cancer cells to palmitate-induced ferroptosis","volume":"17","author":"Closset","year":"2026","journal-title":"Cell Death Dis"},{"key":"B61","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12935-025-03928-2","article-title":"Very long-chain fatty acids accumulate in breast cancer tissue and serum","volume":"25","author":"Pakiet","year":"2025","journal-title":"Cancer Cell Int"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.09.012","article-title":"CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression","volume":"35","author":"Terry","year":"2023","journal-title":"Cell Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000003049","article-title":"Fatty acid-binding proteins in cancers","volume":"111","author":"Wu","year":"2025","journal-title":"Int J Surg"},{"key":"B64","doi-asserted-by":"publisher","first-page":"101353","DOI":"10.1016\/j.plipres.2025.101353","article-title":"Targeting fatty acid-binding protein 4: A therapeutic intersection of obesity and cancer via lipid metabolism","author":"Smoli\u0144ska","year":"2025","journal-title":"Prog Lipid Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"103628","DOI":"10.1016\/j.drudis.2025.104504","article-title":"The emerging role of fatty acid binding protein 5 (FABP5) in cancers","volume":"28","author":"Warren","year":"2023","journal-title":"Drug Discov Today"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/mc.70076","article-title":"Highly expressed fatty acid\u2010binding protein 6 mediates lipid metabolism remodeling in tumor cells via intracellular bile acid transport to promote pancreatic cancer metastasis","volume":"65","author":"Jia","year":"2026","journal-title":"Mol Carcinog"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2025.159661","article-title":"Fatty acid binding protein 1 (FABP1) depletion promotes an oxidative metabolic shift in Caco-2 colorectal cancer cells","volume":"1870","author":"Bor\u00fas","year":"2025","journal-title":"Biochim Biophys Acta (BBA)-Molecular Cell Biol Lipids"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1099459","article-title":"Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment","volume":"14","author":"Surendran","year":"2023","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.13345\/j.cjb.230050","article-title":"Inhibition of CD36 and Nogo-B expression inhibited the proliferation and migration of triple negative breast cancer cells","volume":"39","author":"Wang","year":"2023","journal-title":"Sheng Wu Gong Cheng Xue Bao = Chin J Biotechnol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2812348","article-title":"Fatty acid metabolism: a new perspective in breast cancer precision therapy","volume":"28","author":"He","year":"2023","journal-title":"Front Bioscience-Landmark"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-022-10059-x","article-title":"The adipocyte microenvironment and cancer","volume":"41","author":"Mukherjee","year":"2022","journal-title":"Cancer Metastasis Rev"},{"key":"B72","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41419-025-08239-y","article-title":"Necrotic and apoptotic adipocytes in the hypoxic tumor microenvironment supply triglycerides to induce cisplatin resistance in the metastatic lymph nodes of head and neck carcinoma","volume":"16","author":"Li","year":"2025","journal-title":"Cell Death Dis"},{"key":"B73","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-022-02408-z","article-title":"The pleiotropic roles of adipocyte secretome in remodeling breast cancer","volume":"41","author":"Zhou","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215766","article-title":"Metabolism and polarization regulation of macrophages in the tumor microenvironment","volume":"543","author":"Wang","year":"2022","journal-title":"Cancer Lett"},{"key":"B75","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2025.06.008","article-title":"Lipids and lipoproteins in the interstitial tissue fluid regulate the formation of dysfunctional tissue-resident macrophages: Implications for atherogenic, tumorigenic, and obesogenic processes","volume-title":"Seminars in Cancer Biology","author":"Lee-Rueckert","year":"2025"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110719","article-title":"Tumor-secreted GRP78 induces M2 polarization of macrophages by promoting lipid catabolism","volume":"108","author":"Tian","year":"2023","journal-title":"Cell Signalling"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.885011","article-title":"Enhanced lipid metabolism confers the immunosuppressive tumor microenvironment in CD5-positive non-MYC\/BCL2 double expressor lymphoma","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"dmm050814","DOI":"10.1242\/dmm.050814","article-title":"Metabolic ripple effects\u2013deciphering how lipid metabolism in cancer interfaces with the tumor microenvironment","volume":"17","author":"Jonker","year":"2024","journal-title":"Dis Models Mech"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.04.578802","article-title":"SREBP-dependent regulation of lipid homeostasis is required for progression and growth of pancreatic ductal adenocarcinoma","volume":"4","author":"Ishida","year":"2024","journal-title":"Cancer Res Commun"},{"key":"B80","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3724\/abbs.2025166","article-title":"The role of lipid metabolic interactions in reshaping the tumor microenvironment","volume":"58","author":"Yang","year":"2025","journal-title":"Acta Biochim Biophys Sin"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01531-9","article-title":"Targeting cholesterol metabolism: a promising therapy strategy for cancer","volume":"46","author":"Dai","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B82","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12967-023-04236-x","article-title":"NUCB2\/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway","volume":"21","author":"Ning","year":"2023","journal-title":"J Transl Med"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/biology15010040","article-title":"Multi-omics integration identifies the cholesterol metabolic enzyme DHCR24 as a key driver in breast cancer","volume":"15","author":"Xu","year":"2025","journal-title":"Biology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41419-026-08438-1","article-title":"KDM5B cooperates with CRL4B complex to promote the tumorigenesis of ER+ breast cancer via regulating cholesterol metabolism","volume":"17","author":"Yang","year":"2026","journal-title":"Cell Death Dis"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112605","article-title":"Cholesterol-induced metabolic reprogramming in breast cancer cells is mediated via the ERR\u03b1 pathway","volume":"13","author":"Ghanbari","year":"2021","journal-title":"Cancers"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673396050250729132235","article-title":"The impact of IGFBP6 knockdown on cholesterol metabolism in breast cancer cells","volume":"33","author":"Antipenko","year":"2025","journal-title":"Curr Med Chem"},{"key":"B87","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40170-020-00231-8","article-title":"The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial","volume":"8","author":"Feldt","year":"2020","journal-title":"Cancer Metab"},{"key":"B88","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13058-025-02084-9","article-title":"Fibroblast growth factor receptor signaling modulates cholesterol storage in a SOAT1-dependent manner to promote mammary tumor cell invasion","volume":"27","author":"Tuokkola","year":"2025","journal-title":"Breast Cancer Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.7150\/jca.54637","article-title":"Impact of cholesterol-pathways on breast cancer development, a metabolic landscape","volume":"12","author":"Gonz\u00e1lez-Ortiz","year":"2021","journal-title":"J Cancer"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081765","article-title":"Cholesterol as an endogenous ligand of ERR\u03b1 promotes ERR\u03b1-mediated cellular proliferation and metabolic target gene expression in breast cancer cells","volume":"9","author":"Ghanbari","year":"2020","journal-title":"Cells"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn5295","article-title":"ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells","volume":"8","author":"Luo","year":"2022","journal-title":"Sci Adv"},{"key":"B92","doi-asserted-by":"publisher","first-page":"120088","DOI":"10.1016\/j.bbamcr.2025.120088","article-title":"Anti-tumor response by targeting glucose metabolism and depletion of membrane cholesterol in breast cancer and melanoma cells","author":"Yaduvanshi","year":"2025","journal-title":"Biochim Biophys Acta (BBA)-Molecular Cell Res"},{"key":"B93","first-page":"193","article-title":"Enzymatically formed oxysterols and cell death","volume-title":"Implication of Oxysterols and Phytosterols in Aging and Human Diseases","author":"Urano","year":"2023"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2021.100051","article-title":"4\u03b2-Hydroxycholesterol is a prolipogenic factor that promotes SREBP1c expression and activity through the liver X receptor","volume":"62","author":"Moldavski","year":"2021","journal-title":"J Lipid Res"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3390\/cells12081186","article-title":"Liver X receptor activation attenuates oxysterol-induced inflammatory responses in fetoplacental endothelial cells","volume":"12","author":"George","year":"2023","journal-title":"Cells"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.723224","article-title":"Sterols, oxysterols, and accessible cholesterol: signalling for homeostasis, in immunity and during development","volume":"12","author":"Griffiths","year":"2021","journal-title":"Front Physiol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15273","article-title":"Oxysterols in cancer management: From therapy to biomarkers","volume":"178","author":"Kloudova\u2010Spalenkova","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13495","article-title":"Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early\u2010stage luminal breast cancer","volume":"17","author":"Hol\u00fd","year":"2023","journal-title":"Mol Oncol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112207","article-title":"Tspan6 stimulates the chemoattractive potential of breast cancer cells for B cells in an EV-and LXR-dependent manner","volume":"42","author":"Molostvov","year":"2023","journal-title":"Cell Rep"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-23-01401","article-title":"Lipid droplets in the nervous system: involvement in cell metabolic homeostasis","volume":"20","author":"Zhang","year":"2025","journal-title":"Neural Regener Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1111\/febs.17238","article-title":"Dynamical modelling of lipid droplet formation suggests a key function of membrane phospholipids","volume":"292","author":"Holzh\u00fctter","year":"2025","journal-title":"FEBS J"},{"key":"B102","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/MOL.0000000000000918","article-title":"Intracellular lipase and regulation of the lipid droplet","volume":"35","author":"Cabodevilla","year":"2024","journal-title":"Curr Opin Lipidology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-cellbio-031320-101827","article-title":"Protein quality control and lipid droplet metabolism","volume":"36","author":"Roberts","year":"2020","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100461","article-title":"Altered hepatic lipid droplet morphology and lipid metabolism in fasted Plin2-null mice","volume":"64","author":"Doncheva","year":"2023","journal-title":"J Lipid Res"},{"key":"B105","doi-asserted-by":"publisher","first-page":"841","DOI":"10.7150\/thno.49384","article-title":"ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3","volume":"11","author":"Zhou","year":"2021","journal-title":"Theranostics"},{"key":"B106","first-page":"82","article-title":"Lipid droplets in plants and algae: distribution, formation, turnover and function","volume-title":"Seminars in Cell & Developmental Biology","author":"Ischebeck","year":"2020"},{"key":"B107","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1038\/s41598-025-87871-2","article-title":"Characteristics of different lipid droplet-mitochondrial contacts patterns during lipid droplet metabolism in T2DM-induced MASLD","volume":"15","author":"Xu","year":"2025","journal-title":"Sci Rep"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adf9874","article-title":"Acetyl-CoA carboxylase 1 controls a lipid droplet\u2013peroxisome axis and is a vulnerability of endocrine-resistant ER+ breast cancer","volume":"16","author":"Bacci","year":"2024","journal-title":"Sci Transl Med"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202102136","article-title":"Lipid droplets in the nervous system","volume":"220","author":"Ralhan","year":"2021","journal-title":"J Cell Biol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1177\/25152564241308722","article-title":"The vacuole lipid droplet contact site vCLIP","volume":"7","author":"Diep","year":"2024","journal-title":"Contact"},{"key":"B111","doi-asserted-by":"publisher","first-page":"35","DOI":"10.21203\/rs.3.rs-5510550\/v1","article-title":"Fatty acid synthase-derived lipid stores support breast cancer metastasis","volume":"13","author":"Andolino","year":"2025","journal-title":"Cancer Metab"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02571-3","article-title":"BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells","volume":"42","author":"Rossi","year":"2023","journal-title":"J Exp Clin Cancer Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-024-01047-2","article-title":"Glycolytic enzyme PFKL governs lipolysis by promoting lipid droplet\u2013mitochondria tethering to enhance \u03b2-oxidation and tumor cell proliferation","volume":"6","author":"Meng","year":"2024","journal-title":"Nat Metab"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.848483","article-title":"Choline kinase alpha2 promotes lipid droplet lipolysis in non-small-cell lung carcinoma","volume":"12","author":"Zhu","year":"2022","journal-title":"Front Oncol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15194857","article-title":"The combined inhibition of autophagy and diacylglycerol acyltransferase-mediated lipid droplet biogenesis induces cancer cell death during acute amino acid starvation","volume":"15","author":"Jusovi\u0107","year":"2023","journal-title":"Cancers"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/1873-3468.14808","article-title":"Lipid droplets and fatty acid\u2010induced lipotoxicity: in a nutshell","volume":"598","author":"Obaseki","year":"2024","journal-title":"FEBS Lett"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112925","article-title":"NRF2 regulates lipid droplet dynamics to prevent lipotoxicity","volume":"28","author":"Prevost","year":"2025","journal-title":"iScience"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167576","article-title":"Uncovering the protective role of lipid droplet accumulation against acid-induced oxidative stress and cell death in osteosarcoma","volume":"1871","author":"Cortini","year":"2025","journal-title":"Biochim Biophys Acta (BBA)-Molecular Basis Dis"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-026-01879-y","article-title":"Tumour acidosis remodels the glycocalyx to control lipid scavenging and ferroptosis","volume":"28","author":"B\u00e5ng-Rudenstam","year":"2026","journal-title":"Nat Cell Biol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24680","article-title":"Cancer cells employ lipid droplets to survive toxic stress","volume":"84","author":"Kostecka","year":"2024","journal-title":"Prostate"},{"key":"B121","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1038\/s41467-022-30159-0","article-title":"Regulated IRE1\u03b1-dependent decay (RIDD)-mediated reprograming of lipid metabolism in cancer","volume":"13","author":"Almanza","year":"2022","journal-title":"Nat Commun"},{"key":"B122","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/112_2020_51","article-title":"Lipid droplets in cancer","volume-title":"Organelles in Disease","author":"Petan","year":"2020"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110796","article-title":"Lipogenesis mediated by OGR1 regulates metabolic adaptation to acid stress in cancer cells via autophagy","volume":"39","author":"Pillai","year":"2022","journal-title":"Cell Rep"},{"key":"B124","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41419-025-08093-y","article-title":"TM9SF1 drives the lipophagic flux via AMPK-ULK1 signaling to sustain metabolic fitness in HER2-positive breast cancer","volume":"16","author":"Li","year":"2025","journal-title":"Cell Death Dis"},{"key":"B125","doi-asserted-by":"publisher","first-page":"8301","DOI":"10.1038\/s41467-024-52538-5","article-title":"Specific activation of the integrated stress response uncovers regulation of central carbon metabolism and lipid droplet biogenesis","volume":"15","author":"Labb\u00e9","year":"2024","journal-title":"Nat Commun"},{"key":"B126","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41420-025-02301-6","article-title":"Autophagic flux-lipid droplet biogenesis cascade sustains mitochondrial fitness in colorectal cancer cells adapted to acidosis","volume":"11","author":"Liu","year":"2025","journal-title":"Cell Death Discov"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2022.08.038","article-title":"The regulators of peroxisomal acyl-carnitine shuttle CROT and CRAT promote metastasis in melanoma","volume":"143","author":"Lasheras-Otero","year":"2023","journal-title":"J Invest Dermatol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.10998887","article-title":"Mitochondrial adaptations in acute respiratory distress syndrome","volume":"62","author":"Sanclemente-Cardoza","year":"2024","journal-title":"Rev M\u00e9dica del Instituto Mexicano del Seguro Soc"},{"key":"B129","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12916-021-02185-0","article-title":"Ketone bodies: from enemy to friend and guardian angel","volume":"19","author":"Kolb","year":"2021","journal-title":"BMC Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-020-0169-x","article-title":"Mitochondrial substrate utilization regulates cardiomyocyte cell-cycle progression","volume":"2","author":"Cardoso","year":"2020","journal-title":"Nat Metab"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2023.113737","article-title":"A new strategy to alleviate the obesity induced by endocrine disruptors\u2014a unique lysine metabolic pathway of nanoselenium Siraitia grosvenorii to repair gut microbiota and resist obesity","volume":"175","author":"Wang","year":"2023","journal-title":"Food Chem Toxicol"},{"key":"B132","doi-asserted-by":"publisher","first-page":"189474","DOI":"10.1016\/j.bbcan.2025.189474","article-title":"The role of fatty acid oxidation in the tumor microenvironment: Implications for cancer progression and therapeutic strategies","author":"Rashed","year":"2025","journal-title":"Biochim Biophys Acta (BBA)-Reviews Cancer"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5c00170","article-title":"Metabolomic profiling reveals key metabolic alterations in MCF7 tamoxifen-resistant cells following EPAS1 inhibition","volume":"24","author":"Luo","year":"2025","journal-title":"J Proteome Res"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1925-0","article-title":"SLC22A5\/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE)","volume":"134","author":"Wang","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-12-0304","article-title":"Lipid metabolism genes in contralateral unaffected breast and estrogen receptor status of breast cancer","volume":"6","author":"Wang","year":"2013","journal-title":"Cancer Prev Res"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2025.1542938","article-title":"Impaired peroxisomal beta-oxidation in microglia triggers oxidative stress and impacts neurons and oligodendrocytes","volume":"18","author":"Tawbeh","year":"2025","journal-title":"Front Mol Neurosci"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.m024463","article-title":"Peroxisomal L-bifunctional enzyme (Ehhadh) is essential for the production of medium-chain dicarboxylic acids","volume":"53","author":"Houten","year":"2012","journal-title":"J Lipid Res"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e20224","article-title":"Estrogens and the risk of breast cancer: A narrative review of literature","volume":"9","author":"Al-Shami","year":"2023","journal-title":"Heliyon"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199907000-00014","article-title":"Selective estrogen receptor modulators","volume":"11","author":"Weryha","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.30680","article-title":"Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor\u2010negative breast cancer","volume":"140","author":"Wang","year":"2017","journal-title":"Int J Cancer"},{"key":"B141","doi-asserted-by":"publisher","first-page":"397","DOI":"10.7754\/clin.lab.2014.140902","article-title":"Effect of n-3 and n-6 polyunsaturated fatty acids on lipid metabolic genes and estrogen receptor expression in MCF-7 breast cancer cells","volume":"61","author":"Zhang","year":"2015","journal-title":"Clin Lab"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-25-1339","article-title":"ESR1-activating mutations confer metabolic vulnerabilities in ER+ breast cancer","volume":"86","author":"Bonechi","year":"2026","journal-title":"Cancer Res"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/s41467-021-22101-7","article-title":"The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer","volume":"12","author":"Golden","year":"2021","journal-title":"Nat Commun"},{"key":"B144","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3892\/ol.2025.14921","article-title":"Hypoxia-induced SREBP1-mediated lipogenesis and autophagy promote cell survival via fatty acid oxidation in breast cancer cells","volume":"29","author":"Jung","year":"2025","journal-title":"Oncol Lett"},{"key":"B145","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13046-025-03458-9","article-title":"Adipocytes-induced ANGPTL4\/KLF4 axis drives glycolysis and metastasis in triple-negative breast cancer","volume":"44","author":"Yin","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3390\/biom13020345","article-title":"Liver X receptor inverse agonist GAC0001E5 impedes glutaminolysis and disrupts redox homeostasis in breast cancer cells","volume":"13","author":"Premaratne","year":"2023","journal-title":"Biomolecules"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020756","article-title":"A closer look at estrogen receptor mutations in breast cancer and their implications for estrogen and antiestrogen responses","volume":"22","author":"Clusan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05217","article-title":"XBP1 increases transactivation of somatic mutants of ESR1 and loss of XBP1 reverses endocrine resistance conferred by gain-of-function Y537S ESR1 mutation","volume":"6","author":"Barua","year":"2020","journal-title":"Heliyon"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.867448","article-title":"Decoding the therapeutic implications of the ER\u03b1 stability and subcellular distribution in breast cancer","volume":"13","author":"Tecalco-Cruz","year":"2022","journal-title":"Front Endocrinol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-0013","article-title":"Induction of the TEAD coactivator VGLL1 by estrogen receptor\u2013targeted therapy drives resistance in breast cancer","volume":"84","author":"Gemma","year":"2024","journal-title":"Cancer Res"},{"key":"B151","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-032-06948-1_10","article-title":"Noncoding RNAs in metabolic reprogramming of breast cancer: Dietary opportunities and translational implications","volume-title":"Non-Coding Rnas: Insights on the Regulatory Genome","author":"Mukhlis","year":"2026"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223610","article-title":"Estrogen-inducible LncRNA BNAT1 functions as a modulator for estrogen receptor signaling in endocrine-resistant breast cancer cells","volume":"11","author":"Horie","year":"2022","journal-title":"Cells"},{"key":"B153","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41420-021-00635-5","article-title":"Epigenetic derepression converts PPAR\u03b3 into a druggable target in triple-negative and endocrine-resistant breast cancers","volume":"7","author":"Loo","year":"2021","journal-title":"Cell Death Discov"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/etm.2022.11512","article-title":"Comparison of a histone deacetylase inhibitor plus exemestane with exemestane alone in hormone receptor-positive advanced breast cancer that progressed on prior endocrine therapy: A meta-analysis","volume":"24","author":"Xu","year":"2022","journal-title":"Exp Ther Med"},{"key":"B155","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41594-023-01181-7","article-title":"The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer","volume":"31","author":"Achinger-Kawecka","year":"2024","journal-title":"Nat Struct Mol Biol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3390\/genes13020234","article-title":"Role of the mediator complex and microRNAs in breast cancer etiology","volume":"13","author":"Maldonado","year":"2022","journal-title":"Genes"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146722","article-title":"Long-chain fatty acids alter estrogen receptor expression in breast cancer cells","volume":"26","author":"Ogata","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1458588","article-title":"Mechanisms of tamoxifen resistance: Insight from long non-coding RNAs","volume":"14","author":"Yan","year":"2024","journal-title":"Front Oncol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101876","article-title":"NF1 deficiency drives metabolic reprogramming in ER+ breast cancer","volume":"80","author":"House","year":"2024","journal-title":"Mol Metab"},{"key":"B160","doi-asserted-by":"publisher","first-page":"9495","DOI":"10.1038\/s41598-022-13601-7","article-title":"PSPC1 is a potential prognostic marker for hormone-dependent breast cancer patients and modulates RNA processing of ESR1 and SCFD2","volume":"12","author":"Takeiwa","year":"2022","journal-title":"Sci Rep"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-1161","article-title":"Long-term multimodal recording reveals epigenetic adaptation routes in dormant breast cancer cells","volume":"14","author":"Rosano","year":"2024","journal-title":"Cancer Discov"},{"key":"B162","doi-asserted-by":"publisher","first-page":"104910","DOI":"10.1016\/j.critrevonc.2025.104910","article-title":"Targeting cancer metabolism: Therapeutic potential of the fatty acid synthase (FASN) inhibitors","author":"Nuzzo","year":"2025","journal-title":"Crit Rev Oncology\/Hematology"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2020.108656","article-title":"Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase","volume":"160","author":"Ismail","year":"2020","journal-title":"Steroids"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17040650","article-title":"Lipid metabolism in breast cancer: From basic research to clinical application","volume":"17","author":"Huang","year":"2025","journal-title":"Cancers"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i8.106842","article-title":"Lipid metabolism-related genes in gastric cancer: Exploring oncogenic pathways","volume":"17","author":"Amir","year":"2025","journal-title":"World J Gastrointestinal Oncol"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01581-z","article-title":"STING inhibits the progression of esophageal squamous cell carcinoma by suppressing CPT1A-mediated fatty acid \u03b2-oxidation","volume":"46","author":"Zhang","year":"2025","journal-title":"Acta Pharmacol Sin"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmac055","article-title":"Mechanistic target of rapamycin complex 1: From a nutrient sensor to a key regulator of metabolism and health","volume":"13","author":"Wang","year":"2022","journal-title":"Adv Nutr"},{"key":"B168","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.32604\/or.2025.066440","article-title":"Novel strategies against hepatocellular carcinoma through lipid metabolism","volume":"33","author":"Yang","year":"2025","journal-title":"Oncol Res"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2024.2333991","article-title":"Sesamin regulates breast cancer through reprogramming of lipid metabolism","volume":"44","author":"Patil","year":"2026","journal-title":"J Biomol Struct Dyn"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673320024240829070906","article-title":"ANGPTL4-the link binding lipid metabolism and inflammation","volume":"32","author":"Zhang","year":"2025","journal-title":"Curr Med Chem"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-24-0838","article-title":"MDSCs in breast cancer: Metastasis, lipid metabolism, and therapeutics","volume":"23","author":"Kim","year":"2025","journal-title":"Mol Cancer Res"},{"key":"B172","doi-asserted-by":"publisher","first-page":"157323","DOI":"10.1016\/j.phymed.2025.157323","article-title":"Dual targeting of lipogenesis and PUFAs homeostasis by compound kushen injection suppresses breast cancer bone metastasis","author":"Dai","year":"2025","journal-title":"Phytomedicine"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08917-z","article-title":"Targeting PIKfyve-driven lipid metabolism in pancreatic cancer","volume":"642","author":"Cheng","year":"2025","journal-title":"Nature"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-25-1917","article-title":"FASN inhibition enhances the efficacy of chemotherapy in colorectal cancer by inhibiting the DNA damage response","volume":"86","author":"Banerjee","year":"2026","journal-title":"Cancer Res"},{"key":"B175","doi-asserted-by":"publisher","first-page":"143","DOI":"10.20517\/cdr.2020.54","article-title":"Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer","volume":"4","author":"Chetta","year":"2021","journal-title":"Cancer Drug Resistance"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70116","article-title":"Ferroptosis in pulmonary disease and lung cancer: Molecular mechanisms, crosstalk regulation, and therapeutic strategies","volume":"6","author":"Guo","year":"2025","journal-title":"MedComm"},{"key":"B177","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1021\/acsnano.5c17428","article-title":"Albumin nanoparticles co-loaded with dual drugs for enhanced ferroptosis-based cancer therapy through modulating cholesterol metabolism","volume":"4","author":"Han","year":"2026","journal-title":"ACS Nano"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001808","article-title":"Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers","volume":"136","author":"Yusuf","year":"2020","journal-title":"Blood J Am Soc Hematol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.7150\/ijbs.123647","article-title":"Metabolic reprogramming in urological tumors: New perspectives from tumor metabolic phenotypes to therapeutic targets","volume":"21","author":"Li","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-3242","article-title":"Oxidative phosphorylation is a metabolic vulnerability in chemotherapy-resistant triple-negative breast cancer","volume":"81","author":"Evans","year":"2021","journal-title":"Cancer Res"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-3020","article-title":"Serine biosynthesis is a metabolic vulnerability in IDH2-driven breast cancer progression","volume":"81","author":"Barnabas","year":"2021","journal-title":"Cancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1848165\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:54:25Z","timestamp":1789120465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1848165\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":181,"alternative-id":["10.3389\/fonc.2026.1848165"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1848165","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1848165"}}